Collectively, these findings underscore that the altered expression of SOX9, GATA3, and GATA4 observed in liposarcoma may reflect dysregulated MSC differentiation mechanisms and impaired adipogenic transcriptional control. The gene discussed is SOX9; the disease is liposarcoma.